SCHEMBL685471

SCHEMBL685471

CC(=N)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL8449744 0.95
Propane SCHEMBL28618954 0.88
SCHEMBL17236155 0.76
SCHEMBL12187169 0.76
SCHEMBL12176034 0.73
SCHEMBL12187331 0.73
SCHEMBL8544077 0.73
SCHEMBL13760484 0.73
SCHEMBL19672413 0.70
SCHEMBL23250589 0.70 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117813302-A Substituted tetrahydrofuran-2-carboxamides as sodium channel modulators 沃泰克斯药物股份有限公司 2024-04-02 CN disclosed
US-20230141913-A2 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY Xeniopro GmbH (DE) 2023-05-11 US disclosed
EP-3533795-A1 NOVEL PYRIMIDINE DERIVATIVE HAVING ANTIMALARIAL ACTIVITY Carna Biosciences Inc. (JP) 2019-09-04 EP disclosed
US-9981070-B2 Coating composition and medical device TERUMO KABUSHIKI KAISHA (JP) 2018-05-29 US disclosed
US-20180072726-A9 NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2018-03-15 US disclosed
US-20180000791-A1 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITOR MASSACHUSETTS EYE & EAR INFIRMARY (US) 2018-01-04 US disclosed
US-9783490-B2 Antimicrobial compounds, their synthesis and applications thereof THE SECRETARY OF STATE FOR HEALTH (GB) 2017-10-10 US disclosed
WO-2017161344-A1 COMPOSITIONS AND METHODS FOR TREATING PARASITIC DISEASES THE REGANTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-09-21 WO disclosed
US-20170266326-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS LANTHEUS MEDICAL IMAGING, INC. (US) 2017-09-21 US disclosed
US-20170174620-A1 LINKED DIARYL COMPOUNDS WITH ANTICANCER PROPERTIES AND METHODS OF USING THE SAME UNIVERSITY OF MARYLAND, COLLEGE PARK 2017-06-22 US disclosed
US-20090054488-A1 Isomigrastatin Analogs In The Treatment Of Cancer NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2009-02-26 US disclosed
WO-2008061616-A1 PROCESS FOR PREPARING 2-AMINOOXYETHANOL BAYER CROPSCIENCE AG (DE) 2008-05-29 WO disclosed
EP-1925610-A1 Production process of 2-aminooxyethanol Bayer CropScience AG (DE) 2008-05-28 EP disclosed
WO-2008010921-A2 MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS GILEAD SCIENCES, INC. (US) 2008-01-24 WO disclosed
US-20070060575-A1 Aspartyl protease inhibitors MERCK SHARP & DOHME LLC 2007-03-15 US disclosed
US-20070037852-A1 Migrastatin analogs and uses thereof NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2007-02-15 US disclosed
US-20070037783-A1 Migrastatin analogs and uses thereof NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2007-02-15 US disclosed
CN-1105706-C Cyclic amidino formulations useful as nitric oxide synthase inhibitors SEARLE & CO (US) 2003-04-16 CN disclosed
CN-1305993-A Cyclic guanyl preparation used as nitrogen oxide synthetic enzyme inhibitor SEARLE & CO (US) 2001-08-01 CN disclosed
CN-1189823-A Cyclic amidino formulations useful as nitric oxide synthase inhibitors SEARLE & CO (US) 1998-08-05 CN disclosed